Island Pharmaceuticals (ASX:ILA) Ending Cash Position : A$3.99 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals Ending Cash Position?

Island Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was A$3.99 Mil.

Island Pharmaceuticals's quarterly Ending Cash Position increased from Dec. 2023 (A$0.98 Mil) to Jun. 2024 (A$1.66 Mil) and increased from Jun. 2024 (A$1.66 Mil) to Dec. 2024 (A$3.99 Mil).

Island Pharmaceuticals's annual Ending Cash Position declined from Jun. 2022 (A$4.79 Mil) to Jun. 2023 (A$2.00 Mil) and declined from Jun. 2023 (A$2.00 Mil) to Jun. 2024 (A$1.66 Mil).

Island Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Island Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals Ending Cash Position Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Ending Cash Position

6.46

4.79

2.00

1.66

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial				3.43	2.00	0.98	1.66	3.99

Island Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Island Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.998	+	-0.338
	=	1.66

Island Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.659	+	2.333
	=	3.99

Island Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Bio101 Financial Advisory Pty Ltd, 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.

Island Pharmaceuticals Headlines

No Headlines